Inscrição na biblioteca: Guest
Journal of Environmental Pathology, Toxicology and Oncology

Publicou 4 edições por ano

ISSN Imprimir: 0731-8898

ISSN On-line: 2162-6537

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) IF: 2.4 To calculate the five year Impact Factor, citations are counted in 2017 to the previous five years and divided by the source items published in the previous five years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) 5-Year IF: 2.8 The Immediacy Index is the average number of times an article is cited in the year it is published. The journal Immediacy Index indicates how quickly articles in a journal are cited. Immediacy Index: 0.5 The Eigenfactor score, developed by Jevin West and Carl Bergstrom at the University of Washington, is a rating of the total importance of a scientific journal. Journals are rated according to the number of incoming citations, with citations from highly ranked journals weighted to make a larger contribution to the eigenfactor than those from poorly ranked journals. Eigenfactor: 0.00049 The Journal Citation Indicator (JCI) is a single measurement of the field-normalized citation impact of journals in the Web of Science Core Collection across disciplines. The key words here are that the metric is normalized and cross-disciplinary. JCI: 0.59 SJR: 0.429 SNIP: 0.507 CiteScore™:: 3.9 H-Index: 49

Indexed in

Kirenol Exhibits the Protective Role against N-Methyl-N-Nitrosourea-Induced Gastric Cancer in Rats via Modulating the Oxidative Stress and Inflammatory Markers

Volume 39, Edição 4, 2020, pp. 345-355
DOI: 10.1615/JEnvironPatholToxicolOncol.2020035475
Get accessGet access

RESUMO

Background: Gastric cancer (GC) may arise in any region of the stomach. Poorly diagnosed GC results in almost one million mortalities annually worldwide. Kirenol is a bioactive compound present in the Sieges beckia sps.
Objective: In this current, we investigate the anticancer capacity of kirenol against the MNG-stimulated GC in rats via modulating the antioxidants status and inhibition of NF-κB cascade.
Methodology: GC was provoked in the rats via supplementing 100 mg/kg of MNU through the intragastric route for 16 weeks concomitantly with 30 mg/kg of kirenol treatment. The body weight, tumor volume, and incidence of all animals were tabulated every week. The status of gastrin, ALP, LDH, and γ-GT was studied through the ELISA tests. The lipid peroxidation, enzymatic, and nonenzymatic antioxidants were determined via standard procedures. Expression of thioredoxin, glutaredoxin, NF-κB, TNF-α, IL-6, PGE2 was studied through RT-PCR. The gastric mucosa was analyzed microscopically.
Results: Kirenol treatment appreciably improved the body weight and diminished the tumor volume and incidences in the MNG-challenged rats. The lipid peroxidation was diminished and the enzymatic and non-enzymatic antioxidants were improved by the kirenol treatment. Kirenol suppressed the status of serum markers of GC and gastrin, ALP, LDH, and γ-GT. The mRNA expression of thioredoxin, glutaredoxin, NF-κB, TNF-α, IL-6, PGE2 was downregulated via the kirenol in the MNG-challenged rats. Histopathological analysis result also confirmed the therapeutic role of kirenol.
Conclusion: These findings proved that the kirenol appreciably prevented the MNG-triggered GC in rats and it may become a potential drug for the GC treatment in the future.

Referências
  1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394-424.

  2. Tan P, Yeoh KG. Genetics and molecular pathogenesis of gastric adenocarcinoma. Gastroenterology. 2015;149:1153-62.

  3. Machlowska J, Baj J, Sitarz M, Maciejewski R, Sitarz R. Gastric cancer: Epidemiology, risk factors, classification, genomic characteristics and treatment strategies. Int J Mol Sci. 2020;21(11):4012.

  4. Goto A, Nishikawa J, Ito S, Hideura E, Shirawawa T, Hamabe K, Hashimoto S, Okamoto T, Yanai H, Sakaida I. Estimation of salt intake from spot urine may assist the risk assessment of gastric cancer. J Clin Biochem Nutr. 2020;66(1):74-7.

  5. Hoivik DJ, Allen JS, Wall HG, Nold JB, Miller RT, Santostefano MJ. Studies evaluating the utility of N-methyl-N-nitrosourea as a positive control in carcinogenicity studies in the p53+/- mouse. Int J Toxicol. 2005;24:349-56.

  6. Labbozzetta M, Notarbartolo M, Poma P. Can NF-KB, be considered a valid drug target in neoplastic diseases? Our point of view. Int J Mol Sci. 2020;21(9):3070.

  7. Sukri A, Hanafiah A, Zin NM, Kosai NR. Epidemiology and role of Helicobacter pylori virulence factors in gastric cancer carcinogenesis. APMIS. 2020;128(2);150-61.

  8. Rui LX, Shu SY, Jun WJ, Mo CZ, Wu SZ, Min LS, Yuan L, Yong PJ, Cheng SZ, Sheng WS, Yao TZ. The dual induction of apoptosis and autophagy by SZC014, a synthetic oleanolic acid derivative, in gastric cancer cells via NFkappaB pathway. Tumour Biol J Int Soc Oncodev Biol Med. 2016;37:5133-44.

  9. Zhao S, Wang, Q Li Z, Ma X, Wu L, Ji H, Qin G. LDOC1 inhibits proliferation and promotes apoptosis by repressing NF-kappaB activation in papillary thyroid carcinoma. J Exp Clin Cancer Res. 2015;34:146.

  10. Song ZY, Wu YY, Yang JB, Yang DQ, Fang XD. Progress in the treatment of advanced gastric cancer. Tumour Biol. 2017;39(7). doi: 10.1177/1010428317714626.

  11. Maeda O, Ando Y. Recent progress of chemotherapy and biomarkers for gastroesophageal cancer. World J Gastro-intest Oncol. 2019;11(7):518-26.

  12. Zhang KL, Sui H. Research progress of immunotherapy for gastric cancer. J Clin Oncol. 2019;25(8):685-90.

  13. Salehifar E, Avan R, Janbabaei G, Mousavi SK, Faramarzi F. Comparison the incidence and severity of side effects profile of FOLFOX and DCF regimens in gastric cancer patients. Iran J Pharm Res. 2019;18(2):1032-9.

  14. Wang ZM, Zhu SG, Wu ZW, Lu Y, Fu HZ, Qian RQ. Kirenol upregulates nuclear Annexin-1 which interacts with NF-KB to attenuate synovial inflammation of collagen-induced arthritis in rats. J Ethnopharmacol. 2011;137:774-82.

  15. Lu Y, Xiao J, Wu Z, Wang Z, Fu H, Chen Y, Qian R. Effects of kirenol on bovine type II collagen-induced rat lymphocytes in vivo and in vitro. J South Med Univ. 2012;32(1):1-5.

  16. Lu Y, Xiao J, Chen YY, Qian RQ. Kirenol exerts a potent anti-arthritic effect in collagen-induced arthritis by modi-fying the T cells balance. Phytomedicine. 2012;19:882-9.

  17. Chou GX, Jin RM, Wang ZT, Chen CX. Study on anti-thrombotic fraction of Herba siegesbeckiae. J Chin Med Mater. 2006;29:235-7.

  18. Kim MB, Song Y, Hwang JK. Kirenol stimulates osteoblast differentiation through activation of the BMP and Wnt/p-catenin signaling pathways in MC3T3-E1 cells. Fitoterapia. 2014;98:59-65.

  19. Lu Y, Qian R, Xiao J, Xu D, Fu H, Chen Y. Kirenol, a compound from Herba Siegesbeckiae, induces apoptosis in human chronic myeloid leukemia K562 cells. Pharmazie. 2014;69:148-53.

  20. Kim MB, Song Y, Kim C, Hwang J. Kirenol inhibits adipogenesis through activation of the Wnt/p-catenin signaling pathway in 3T3-L1 adipocytes. Biochem Biophys Res Commun. 2014;445:433-8.

  21. Wu J, Li Q, Jin L, Qu Y, Liang BB, Zhu XT, Du HY, Jie LG. Kirenol inhibits the function and inflammation of fibroblast-like synoviocytes in rheumatoid arthritis in vitro and in vivo. Front Immunol. 2019;10:1304.

  22. Xiuhong L, Yajun D, Guoxing L, Guomei D, Xin T, Juan X. Kirenol relieves dextran sulfate sodium-induced ulcerative colitis in mice by inhibiting inflammatory cytokines and inducing CD4+ T lymphocyte apoptosis. J South Med Univ. 2019;39(12):1387-92.

  23. Wu B, Huang XY, Li L, Fan XH, Li PC, Huang CQ, Xiao J, Gui R, Wang S. Attenuation of diabetic cardiomyopathy by relying on kirenol to suppress inflammation in a diabetic rat model. J Cell Mol Med. 2019;23(11):7651-63.

  24. Upp JR, Beauchamp RD, Townsend CM, Barranco SC, Singh P, Rajaraman S, James E, Thompson JC. Inhibition of human gastric adenocarcinoma xenograft growth in nude mice by a-Difluoromethylornithine. Cancer Res. 1988;48(11):3265-69.

  25. Niehius WG, Samuelson B. Formation of malondialdehyde from phospholipid arachidonate during microsomal lipid peroxidation. Eur J Biochem. 1968;6:126-30.

  26. Kakkar P, Das B, Viswanathan PN. A modified spectroscopic assay of superoxide dismustase. Indian J Biochem Biophys. 1984;21:130-2.

  27. Sinha AK. Colorimetric assay of catalase. Anal Biochem. 1972;47:389-94.

  28. Rotruck JT, Pope AL, Ganther HE. Selenium: Biochemical role as a component of glutathione peroxidase purification assay. Science. 1973;179:588-90.

  29. Ellman GL. Tissue sulfhydryl groups. Arch Biochem Bio-phys. 1959;82:70-7.

  30. Martinek RG. Method for the determination of vitamin E (total tocopherol) in serum. Clin Chem. 1964;10:1078.

  31. Roe JH, Kuether CA. The determination of ascorbic acid in whole blood and urine through 2,4 dinitro phenyl hydrazine derivative of dehydro ascorbic acid. J Biol Chem. 1943;147:399.

  32. Gullo I, Carneiro F, Oliveira C, Almeida GM. Heterogeneity in gastric cancer: From pure morphology to molecular classifications. Pathobiology. 2018;85(1-2):50-63.

  33. Zhai J, Shen J, Xie G, Wu J, He M, Gao L, Zhang Y, Yao X, Shen L. Cancer associated fibroblasts-derived IL-8 mediates resistance to cisplatin in human gastric cancer. Cancer Lett. 2019;454:37-43.

  34. Shao L, Chen Z, Soutto M, Zhu S, Lu H, Romero-Gallo J, Peek R, Zhang S, El Rifai W. Helicobacter pylori-induced miR-135b-5p promotes cisplatin resistance in gastric cancer. FASEB J. 2019;33:264-74.

  35. Rebollido-Rios R, Venton G, Sanchez-Redondo S, Iglesias IFC, Fournet G, Gonzalez E, Romero Fernandez W, Borroto Escuela DO, Di Stefano B, Penarroche-Diaz R, Martin G, Ceylan I, Contello R, Perez-Alea M. Dual disruption of aldehyde dehydrogenases 1 and 3 promotes functional changes in the glutathione redox system and enhances chemosensitivity in nonsmall cell lung cancer. FASEB J. 2019;33:264-74.

  36. Silva MM, Rocha CRR, Kinker GS, Pelegrini AL, Menck CFM. The balance between NRF2/GSH antioxidant mediated pathway and DNA repair modulates cisplatin resistance in lung cancer cells. Sci Rep. 2019;9:17639.

  37. Solis-Martinez O, Plasa-Carvalho V, Phillips-Sixtos G. Effect of Eicosapentaenoic acid on body composition and inflammation markers in patients with head and neck squamous cell cancer from a public hospital in Mexico. Nutr Cancer. 2018;70:663-70.

  38. Wu R, Feng J, Yang Y, Dai C, Lu A, Li J, Liao Y, Xiang M, Huang Q, Wang D, Du XB. Significance of serum total oxidant/antioxidant status in patients with colorectal cancer. PLoS One. 2017;12:e0170003.

  39. Zhong H, Yin H. Role of lipid peroxidation derived 4-hydroxynonenal (4-HNE) in cancer: Focusing on mitochondria. Redox Biol. 2015;4:193-9.

  40. Harris IS, Treloar AE, Inoue S, Sasaki M, Gorrini C, Lee KC, Yung KY, Brenner D, Knobbe-Thomsen CB, Cox MA, Elia A. Glutathione and thioredoxin antioxidant pathways synergize to drive cancer initiation and progression. Cancer Cell. 2015 Feb 9;27(2):211-22.

  41. Camarena V, Wang G. The epigenetic role of vitamin C in health and disease. Cell Mol Life Sci. 2016;73: 1645-58.

  42. Lei XG, Zhu JH, Cheng WH, Bao Y, Ho YS, Reddi AR, Holmgren A, Arner SJ. Paradoxical roles of antioxidant enzymes: Basic mechanisms and health implications. Physiol Rev. 2016;96(1):307-64.

  43. Ivanova DG, Yaneva ZL. Antioxidant properties and redox-modulating activity of chitosan and its derivatives: Biomaterials with application in cancer therapy. Biores Open Access. 2020;9(1):64-72.

  44. Boyce M, Moore AR, Sagatun L, Parsons BN, Varro A, Campbell F, Fossmark R, Waldum HL, Pritchard DM. Netazepide, a gastrin/cholecystokinin-2 receptor antagonist, can eradicate gastric neuroendocrine tumours in patients with autoimmune chronic atrophic gastritis. British J Clin Pharmacol. 2017 Mar;83(3):466-75.

  45. Tsukamoto H, Mizoshita T, Katano T, Hayashi N, Ozeki K, EBI M, Shimura T, Mori Y, Tanida S, Kataoka H, Tsukamoto T, Tatematsu M, Joh T. Preventive effect of rebamipide on N-methyl-N'-nitro-N-nitrosoguanidine-induced gastric carcinogenesis in rats. Exp Toxicol Pathol. 2015;67:271-7.

  46. Ye DM, Xu G, Ma W, Li Y, Luo W, Xiao Y, Liu Y, Zhang Z. Significant function and research progress of biomarkers in gastric cancer. Oncol Lett. 2020;19(1):17-29.

  47. Watanabe H, Yoneda S, Motoyama Y, Mukai K, Okuno Y, Kozawa J, Nishizawa H, Maeda N, Otsuki M, Matsuoka T, Morii E, Iwahashi H, Shimomura I. Marked hypergastrinema with G-cell hyperplasia in two autoimmune gastritis patients. Intern Med. 2020;59(60): 799-803.

  48. Smith JP, Nadella S, Osbome N. Gastrin and gastric cancer. Cell Mol Gastroenterol Hepatol. 2017;4(1):75-83.

  49. Shang W, Xie Z, Lu F, Fang D, Tang T, Bi R, Chen L, Jiang L. Increased thioredoxin-1 expression promotes cancer progression and predicts poor prognosis in patients with gastric cancer. Oxid Med Cell Longev. 2019;2019:9291683.

  50. Bhatia M, McGrath KL, Di Trapani G, Charoentong P, Shah F, King MM, Clarke FM, Tonissen KF. The thioredoxin system in breast cancer cell invasion and migration. Redox Biol. 2016;8:68-78.

  51. Babiuch K, Kusbierz-Cabala B, Kesek B, Okon K, Darczuk D, Chomyszyn-Gajewska M. Evaluation of proinflammatory, NF-kappaB dependent cytokines: IL-1a, IL-6, IL-8, and TNF-a in tissue specimens and saliva of patients with oral squamous cell carcinoma and oral potentially malignant disorders. J Clin Med. 2020;9(3):867.

  52. Park MH, Hong JT. Roles of NF-KB in cancer and inflammatory diseases and their therapeutic approaches. Cells. 2016;5(2):15.

  53. Matthews GM, de Matos Simoes R, Dhimolea E, Sheffer M, Gandolfi S, Dashevsky O, Sorrell JD, Midsiades CS. NF-KB dysregulation in multiple myeloma. Semin Cancer Biol. 2018;39:68-76.

  54. Teng H, Xue L, Wang Y, Ding X, Li J. Nuclear factor KB-inducing kinase is a diagnostic marker of gastric cancer. Medicine (Baltimore). 2020;99(5):e18864.

CITADO POR
  1. Wang Yulong, Xu Jia, Alarifi Saud, Wang Huanjun, Kirenol inhibited the cell survival and induced apoptosis in human thyroid cancer cells by altering PI3K / AKT and MAP kinase signaling pathways , Environmental Toxicology, 36, 5, 2021. Crossref

  2. Ibrahim Sabrin R.M., Altyar Ahmed E., Sindi Ikhlas A., El-Agamy Dina S., Abdallah Hossam M., Mohamed Shaimaa G.A., Mohamed Gamal A., Kirenol: A promising bioactive metabolite from siegesbeckia species: A detailed review, Journal of Ethnopharmacology, 281, 2021. Crossref

  3. AbuZahra H. M., Kirenol protects against oxidized low-density lipoprotein induced damages in endothelial cells, Brazilian Journal of Biology, 84, 2024. Crossref

  4. Hu Wei, Mao Chao, Sheng Weibin, The protective effect of kirenol in osteoarthritis: an in vitro and in vivo study, Journal of Orthopaedic Surgery and Research, 17, 1, 2022. Crossref

  5. Zhao Maoyuan, Wei Feng, Sun Guangwei, Wen Yueqiang, Xiang Juyi, Su Fangting, Zhan Lu, Nian Qing, Chen Yu, Zeng Jinhao, Natural compounds targeting glycolysis as promising therapeutics for gastric cancer: A review, Frontiers in Pharmacology, 13, 2022. Crossref

1631 Visualizações do artigo 131 downloads de artigos Métricas
1631 VISUALIZAÇÕES 131 TRANSFERÊNCIAS 5 Crossref CITAÇÕES Google
Scholar
CITAÇÕES

Artigos com conteúdo semelhante:

Neferine Inhibits 7,12-Dimethylbenz(a)anthracene-Induced Mammary Tumorigenesis by Suppression of Cell Proliferation and Induction of Apoptosis via Modulation of the PI3K/AKT/NF-κB Signaling Pathway Journal of Environmental Pathology, Toxicology and Oncology, Vol.40, 2021, issue 3
Xiaoying Lin, Ying Xiong, Zhongli Sun, Huaikun Ni, Linhan Yang
Diosmin Regulates Oxidative Stress and Inflammatory Marker Levels in N-Methyl-N-Nitrosourea-Induced Gastric Carcinogenesis in Rats Journal of Environmental Pathology, Toxicology and Oncology, Vol.39, 2020, issue 4
Weiwei Liu, Jing Zhang, Yixiu Zhao
Mangiferin Inhibits Inflammation and Cell Proliferation, and Activates Proapoptotic Events via NF-κB Inhibition in DMBA-Induced Mammary Carcinogenesis in Rats Journal of Environmental Pathology, Toxicology and Oncology, Vol.40, 2021, issue 2
Xin Wang, Tong Yuwen, Tian Yanqin
Immunomodulatory Effect of Eriocitrin in Experimental Animals with Benzo(a)Pyrene-induced Lung Carcinogenesis Journal of Environmental Pathology, Toxicology and Oncology, Vol.39, 2020, issue 2
Qing Wang, Meifang Huang, Yuanyuan Zheng, Kai Zheng, Liqiong Zhang
PI3K/Akt Pathway and miR-21 are Involved in N-Ethyl-N-Nitrosourea-Induced F1 Mouse Lung Tumorigenesis: Effect of Inositol Hexaphosphate Journal of Environmental Pathology, Toxicology and Oncology, Vol.38, 2019, issue 1
Prakash Tiwari, Satya Sahay, Manuraj Pandey, Krishna P. Gupta
Portal Digital Begell Biblioteca digital da Begell eBooks Diários Referências e Anais Coleções de pesquisa Políticas de preços e assinaturas Begell House Contato Language English 中文 Русский Português German French Spain